10.1055/s-0032-1311548 45
Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
KellyASAuerbachPBarrientos-PerezMGiesIHalePMMarcusCet alA randomized, controlled trial of liraglutide for adolescents with obesity
Sertraline is available in pill and a liquid concentrate, but the concentrate needs to be diluted to prevent a numbing sensation in the mouth that can last up to a day
Q: What is the difference between Orange Book patent expiry and effective exclusivity
men should report severe abdominal pain or persistent vomiting to their clinician promptly